Speaker(s): 

Dr. David Altschul MD; Discloures -

• Consultant: Stryker, Microvention, J&J,Route 92, Synchron, Viz AI, Longeviti,Penumbra, Cerevasc​

• Advisory Board: Sirtex, BE Therapeutics,Glia Medical​

• Investments: Von Vascular, Synchron​

• Household: Siemens, NTI​

• I am not a surfer, I have never surfed butI greatly appreciate it

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• What caused the Dutch to trade awaythe island of Manhattan​

• Name a new Endovascular device beingstudied for FDA approval

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Edward Monaco, III MD, PhD, Christopher Berry, DMSc, PA-C, and Maurissa Cropf have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None